Page last updated: 2024-08-22

n-methylaspartate and sulfasalazine

n-methylaspartate has been researched along with sulfasalazine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, SY; Choi, JS; Chung, JM; Gwag, BJ; Joo, CK; Lee, YA; Noh, JH; Ryu, BR; Won, SJ; Yoon, SH1
Ahn, YM; Byun, HY; Cho, JY; Cho, SI; Chung, JM; Gwag, BJ; Im, DS; Kim, KW; Ko, SY; Kwon, HJ; Lee, HU; Lee, JY; Lee, MJ; Lee, YA; Lim, HR; Moon, HS; Noh, JH; Park, SM; Son, SJ; Won, SJ; Yoon, SH; Yun, BS1

Other Studies

2 other study(ies) available for n-methylaspartate and sulfasalazine

ArticleYear
The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1

    Topics: Animals; Antioxidants; Calcium; Cells, Cultured; Cerebral Cortex; Cyclooxygenase 2; Disease Models, Animal; Ischemia; Isoenzymes; Male; Mice; Mice, Inbred ICR; N-Methylaspartate; Neuroprotective Agents; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Retinal Diseases; Sulfasalazine

2003
Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2007, Volume: 27, Issue:6

    Topics: Animals; Antioxidants; Aspirin; Benzoates; Brain Ischemia; Cells, Cultured; Excitatory Amino Acid Antagonists; Fluorobenzenes; Infarction, Middle Cerebral Artery; meta-Aminobenzoates; Mice; N-Methylaspartate; Oxidative Stress; Receptors, N-Methyl-D-Aspartate; Salicylates; Sulfasalazine

2007